Does Morgan Stanley’s Leverage Concerns Change The Bull Case For Celanese (CE)?

• Morgan Stanley recently resumed coverage of Celanese with an Equal Weight rating, emphasizing concerns over the company’s elevated leverage and weaker profitability metrics.
• This renewed scrutiny puts Celanese’s balance sheet and cash generation under the microscope, making capital structure discipline a central issue for investors.
• We’ll now examine how Morgan Stanley’s focus on Celanese’s leverage and profitability reshapes the company’s investment narrative for shareholders.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 32 best rare earth metal stocks of the very few that mine this essential strategic resource.

What Is Celanese's Investment Narrative?

For Celanese, the big picture an investor needs to believe in is a turnaround from today’s heavy losses and high leverage to a steadier, cash-generative chemicals business, supported by a seasoned but recently refreshed board and management team. The key short term catalysts still sit around execution: improving profitability from a US$9.71 billion revenue base, restoring balance sheet strength so interest costs are better covered, and rebuilding confidence after the steep dividend cut. Morgan Stanley’s Equal Weight rating and lower US$50 target price largely reinforce existing concerns rather than introduce new ones, but they do sharpen the focus on leverage as the central risk and on free cash flow as the main yardstick. The recent price drop suggests this scrutiny could modestly temper near term enthusiasm, without fundamentally changing the long term thesis.

However, one financial pressure point now matters more than ever and investors should not ignore it. Celanese's shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be.

Exploring Other Perspectives

Seven Simply Wall St Community fair value estimates span about US$51.50 to just under US$124, reflecting wide disagreement on upside. Set those views against Celanese’s high leverage and weak profitability, and it becomes clear why different investors may reach very different conclusions about the company’s trajectory.

Explore 7 other fair value estimates on Celanese - why the stock might be worth just $51.50!

Build Your Own Celanese Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Celanese research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Celanese research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Celanese's overall financial health at a glance.

Want Some Alternatives?

Our top stock finds are flying under the radar-for now. Get in early:

• Uncover the next big thing with financially sound penny stocks that balance risk and reward.
• These 10 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com